RecruitingNCT05201131

Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).


Sponsor

Can-Am HIFU Inc.

Enrollment

50 participants

Start Date

Oct 7, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

To document the clinical outcome of Rezūm therapy for BPH patient in Canadian cohort.


Eligibility

Sex: MALEMin Age: 18 Years

Inclusion Criteria5

  • Male subjects of ≥ 18 years of age.
  • Primary diagnosis of Benign Prostate Hypertrophy (BPH).
  • Candidate for Rezūm therapy as per clinical decision of Investigator.
  • Willing and able to accurately complete the required questionnaires.
  • Willing and able to provide signed and dated informed consent

Exclusion Criteria3

  • Characteristics indicating a poor compliance with study protocol requirements.
  • Disease or other health condition that is not suitable for this study.
  • Unable or unwilling to provide signed informed consent.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURERezum

Rezum


Locations(1)

Dean Elterman

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05201131


Related Trials